JP2025500483A5 - - Google Patents
Info
- Publication number
- JP2025500483A5 JP2025500483A5 JP2024538263A JP2024538263A JP2025500483A5 JP 2025500483 A5 JP2025500483 A5 JP 2025500483A5 JP 2024538263 A JP2024538263 A JP 2024538263A JP 2024538263 A JP2024538263 A JP 2024538263A JP 2025500483 A5 JP2025500483 A5 JP 2025500483A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- hvr
- monoclonal antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163292863P | 2021-12-22 | 2021-12-22 | |
| US63/292,863 | 2021-12-22 | ||
| US202263383451P | 2022-11-11 | 2022-11-11 | |
| US63/383,451 | 2022-11-11 | ||
| US202263387229P | 2022-12-13 | 2022-12-13 | |
| US63/387,229 | 2022-12-13 | ||
| PCT/US2022/082139 WO2023122665A1 (en) | 2021-12-22 | 2022-12-21 | Clinical formulations of anti-tigit antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025500483A JP2025500483A (ja) | 2025-01-09 |
| JP2025500483A5 true JP2025500483A5 (https=) | 2025-12-24 |
Family
ID=85199491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024538263A Pending JP2025500483A (ja) | 2021-12-22 | 2022-12-21 | 抗ｔｉｇｉｔ抗体の臨床製剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240408009A1 (https=) |
| EP (1) | EP4452320A1 (https=) |
| JP (1) | JP2025500483A (https=) |
| KR (1) | KR20240121771A (https=) |
| AU (1) | AU2022417501A1 (https=) |
| CA (1) | CA3242136A1 (https=) |
| IL (1) | IL313658A (https=) |
| MX (1) | MX2024007749A (https=) |
| TW (1) | TW202330034A (https=) |
| WO (1) | WO2023122665A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202515614A (zh) | 2023-08-25 | 2025-04-16 | 美商建南德克公司 | 治療非小細胞肺癌之方法及組成物 |
| WO2025174933A1 (en) | 2024-02-14 | 2025-08-21 | Genentech, Inc. | Methods for treatment of pancreatic cancer with anti-pd-l1 ab, anti-tigit ab, gemcitabine and nab-placlitaxel |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6075181A (en) | 1990-01-12 | 2000-06-13 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| KR20220113414A (ko) | 2019-12-09 | 2022-08-12 | 제넨테크, 인크. | 항-pd-l1 항체 제제 |
| CN115052622B (zh) * | 2020-01-21 | 2026-03-06 | 夏尔巴生物技术(杭州)有限公司 | 重组全人源抗tigit单克隆抗体制剂及其制备方法和用途 |
| TW202142230A (zh) * | 2020-01-27 | 2021-11-16 | 美商建南德克公司 | 用於以抗ｔｉｇｉｔ拮抗體抗體治療癌症之方法 |
-
2022
- 2022-12-21 AU AU2022417501A patent/AU2022417501A1/en active Pending
- 2022-12-21 CA CA3242136A patent/CA3242136A1/en active Pending
- 2022-12-21 JP JP2024538263A patent/JP2025500483A/ja active Pending
- 2022-12-21 EP EP22854694.1A patent/EP4452320A1/en active Pending
- 2022-12-21 IL IL313658A patent/IL313658A/en unknown
- 2022-12-21 MX MX2024007749A patent/MX2024007749A/es unknown
- 2022-12-21 WO PCT/US2022/082139 patent/WO2023122665A1/en not_active Ceased
- 2022-12-21 KR KR1020247021095A patent/KR20240121771A/ko active Pending
- 2022-12-22 TW TW111149551A patent/TW202330034A/zh unknown
-
2024
- 2024-06-20 US US18/749,129 patent/US20240408009A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023517236A5 (https=) | ||
| JP2024016177A5 (https=) | ||
| JP2021514969A5 (https=) | ||
| JP2016533335A5 (https=) | ||
| JP2020518600A5 (https=) | ||
| JP2025172841A5 (https=) | ||
| CN108601831A (zh) | 一种抗pd-1抗体和vegfr抑制剂联合在制备治疗癌症的药物中的用途 | |
| JP2024174962A5 (https=) | ||
| BR112021008778A2 (pt) | Métodos de tratamento da oftalmopatia de graves usando anticorpos anti-fcrn | |
| JP2021501214A5 (https=) | ||
| JP2015530867A5 (https=) | ||
| JP2023504748A5 (https=) | ||
| JP2020158505A5 (https=) | ||
| JP2025500483A5 (https=) | ||
| JP2022532927A5 (https=) | ||
| JP2024531151A5 (https=) | ||
| JP2019521156A5 (https=) | ||
| JP2022512704A5 (https=) | ||
| WO2019020069A1 (zh) | 一种sost抗体药物组合物及其用途 | |
| WO2023061472A1 (zh) | 抗her2抗体药物偶联物和酪氨酸激酶抑制剂联合在制备治疗肿瘤的药物中的用途 | |
| JP2024515968A5 (https=) | ||
| JP2023551734A5 (https=) | ||
| JP2019524820A5 (https=) | ||
| JP2019519584A5 (https=) | ||
| RU2016128223A (ru) | Лечение вируса гриппа а h7n9 |